ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Coronary Disease

March 13, 2016
This Belgian study prospectively analyzed the predictors of long-term mortality in a group of 107 consecutive CABG patients with an LV EF < 35%.  All patients underwent preoperative Cardiac MR to assess both LV and RV EF.
March 13, 2016
The authors reviewed the Medicare database to analyze the trends in CABG surgery within this population over a 12-year period.  Trends in the Medicare population included the following:
March 11, 2016
The authors provide an excellent overview of the rationale for screening all patients with a new diagnosis of cardiomyopathy for coronary artery disease.  This rationale includes the following:
February 18, 2016
An Editorial suggesting that atheroma is here to stay...
January 30, 2016
Outcomes of CABG for patients in cardiogenic shock after acute MI were evaluated using data from the STS Database.  The study group of nearly 5,500 patients comprised 1.5% of all CABG patients during the study period.  Operative mortality was 18.7%.  Mechanical circulatory support use was most common in patients with more risk factors or high clinica
January 13, 2016
Comprehensive review article on the role of periperative statin therapy in patients undergoing coronary revascularization.  
January 9, 2016
The authors performed a randomized control study of 178 patients with heart failure and systolic dyssynchrony who were accepted for CABG, randomizing the participants into two groups:  CABG alone (n=87) and CABG + concomitant epicardial CRT (n=91).  CRT was activated postoperatively.
December 26, 2015
Using CMS CABG data as a denominator, the investigators examined the penetration, completeness, and representativeness of the STS database with respect to the CMS database.  The investigators found that, in 2012--the most recent year analyzed--center-level penetration was 90% and patient-level penetration was 94%.
December 16, 2015
PREVENT IV trial participants who had undergone either a RIMA or LIMA to LAD anastomosis and underwent an angiogram at 1 to 1.5 years (n=1539) were analyzed for mammary graft failure (defined as >75% stenosis).
December 10, 2015
A growing body of evidence demonstrates improved short, mid, and long term outcomes with the use of arterial conduits for coronary revascularization.  Despite this, less than 10% of patients receive more than 2 arterial grafts.

Pages